Rutoside decreases human macrophage-derived inflammatory mediators and improves clinical signs in adjuvant-induced arthritis
2008

Rutoside Reduces Inflammation in Arthritis

Sample size: 5 publication 10 minutes Evidence: moderate

Author Information

Author(s): Kauss Tina, Moynet Daniel, Rambert Jérôme, Al-Kharrat Abir, Brajot Stephane, Thiolat Denis, Ennemany Rachid, Fawaz Fawaz, Mossalayi M Djavad

Primary Institution: Bordeaux 2 University

Hypothesis

Can rutoside modulate inflammatory mediators in human macrophages and improve arthritis symptoms in a rat model?

Conclusion

Rutoside may help reduce inflammation in human arthritis and other inflammatory diseases.

Supporting Evidence

  • Rutoside inhibited the release of proinflammatory cytokines from activated human macrophages.
  • Rutoside improved clinical signs of arthritis in a rat model.
  • Treatment with Rutoside resulted in decreased levels of TNF-α, IL-1β, and IL-6.
  • Rutoside showed a significant effect on reducing arthritis severity scores in rats.

Takeaway

Rutoside is a natural compound that can help make people with arthritis feel better by reducing inflammation.

Methodology

Rutoside was tested on human macrophages and in a rat model of arthritis, measuring inflammatory markers and clinical signs.

Potential Biases

Potential bias in the selection of treatment groups and the subjective assessment of clinical signs.

Limitations

The study primarily focused on a rat model, which may not fully represent human conditions.

Participant Demographics

Healthy volunteers provided blood samples for human cell experiments.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1186/ar2372

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication